The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1248 Weight Loss articles
Country star Jelly Roll has shed an astonishing 275 pounds since 2022, transforming his life without relying on GLP-1 medications like Ozempic, Wegovy, or Mounjaro. His story highlights the power of addressing food addiction through therapy, consistent exercise, and mindful eating—proving that peptide therapy alternatives can yield profound, lasting change.
New data shows many patients cycle on and off GLP-1 medications. Discover why this approach may hinder long-term health and why tracking is essential.
As new weight-loss medications enter the UAE market, patients are questioning insurance coverage. We break down the realities of policy, medical necessity, and the future of metabolic health.
Rebel Wilson's transformation is more than a celebrity headline; it's a masterclass in metabolic health. Discover the role of GLP-1s, the science of consistency, and why moderation beats intensity.
The FDA is evaluating the regulation of specific peptides amid growing demand. We break down the science, the risks, and the clinical implications.
The federal government has extended its commitment to fund GLP-1 obesity medications through 2027, shifting away from private insurer mandates to protect seniors from premium hikes.
A new study in Obesity Pillars suggests that while GLP-1 drugs aid weight loss, they may impact sexual desire through brain chemistry. Here is what you need to know.
A new lifetime economic analysis suggests tirzepatide may offer superior long-term value and clinical outcomes compared to semaglutide for obesity management.
Is your GLP-1 medication affecting your mood? Discover the science behind anhedonia, the 'Ozempic personality' phenomenon, and what experts say about dopamine and metabolic health.
